Division of Cardiology, University of Washington, Seattle, WA.
Division of Cardiology, University of Washington, Seattle, WA.
Trends Cardiovasc Med. 2016 Aug;26(6):526-35. doi: 10.1016/j.tcm.2016.03.004. Epub 2016 Mar 15.
The subcutaneous implantable cardioverter-defibrillator (ICD) was developed as a simple device to reduce the morbidity of ICD therapy while providing a comparable reduction in sudden death from ventricular fibrillation. This review highlights the differences compared to the traditional ICD. It includes recent data on safety and efficacy, as well as best practices on screening and programming, and discusses expected future developments.
皮下植入式心脏复律除颤器 (ICD) 的开发是为了提供一种简单的设备，以降低 ICD 治疗的发病率，同时提供可比的减少因心室颤动导致的猝死。本综述强调了与传统 ICD 的差异。它包括最近的安全性和有效性数据，以及关于筛查和编程的最佳实践，并讨论了预期的未来发展。
